Wave Bioreactors Added to Macrogenics cGMP Manufacturing Facility
News Jan 12, 2006
The Wave Bioreactors® will enable MacroGenics - which is focused on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases - to produce monoclonal antibodies under current Good Manufacturing Practice standards.
"Wave Biotech's disposable cell culture technology is ideal for the MacroGenics application because it is scalable, up to 500 liters," said Vijay Singh, founder & president of Wave Biotech.
"Our large scale bioreactors use proprietary technology which has been tested and refined for the last 5 years, and we can also roll-in a large scale 500 liter production capability bioreactor into an existing facility today, without the requirements of piping or steam," added Singh, whom is the inventor of the Wave Bioreactor®.
Further he said, "There is no waiting period. All that is needed is to plug and play."
MacroGenics officially opened their new manufacturing facility on October 19th.
Antitumor Immune Function in Liver Controlled by Gut MicrobiomeNews
Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. The study showed that bacteria found in the gut of mice affect the liver’s antitumor immune function. The findings have implications for understanding the mechanisms that lead to liver cancer and for therapeutic approaches to treat them.READ MORE
You Are What Your Mother EatsNews
While many factors, such as the age of the mother, overall health and genetics ultimately play a role, the correlation between a mother’s nutrition habits and metabolism has been proved to directly impact the growth of her child. And researchers believe they may be one step closer to knowing why.READ MORE
Immune Cells Form Clots in Tumors Aiding Lung Cancer's SpreadNews
Researchers have found that by helping to form clots within tumors, immune cells that flock to a particular type of lung cancer are actually building a foundation for the tumor to spread within the body.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018